2860 Correlation between plasma Epstein-Barr virus DNA and clinical response to pembrolizumab in patients with advanced or metastatic nasopharyngeal carcinoma. (September 2015) - Kao, H.F.; Hsu, C.; Huang, H.C.; Wang, C.W.; Cheng, J.D.; Hong, R.L.